Skip to main content
OpenTrials
Completed

NCT Number: NCT02793180

Documentation of Heart Failure in a Gulf Registry

In the Middle East and the Gulf, the general population have high cardiovascular risks like diabetes, hypertension, smoking and obesity. The average age of a patient with an acute coronary syndrome (ACS) event is relatively young compared to Western populations. Women are multiparous and the rates of consanguinity marriages are high in this region of the world. These risk factors and conditions result in heart failure. Great deal of knowledge is missing regarding the influence of these risk factors on heart failure presentation, the causes and management of heart failure in ambulatory patients in this region of the world.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Adan Hospital, Kuwait City, Kuwait

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Is over the age of 21.
  • Has been diagnosed with heart failure, regardless of cause.
  • Is presenting to the outpatient clinic of an internist or cardiologist for follow up.
  • Provides a written consent.

Exclusion criteria

  • Prior enrolment in this study.
  • Refusal or inability to provide consent.

Treatment and study plan

Primary outcomes

  1. Quantifying the causes of heart failure in the ambulatory patients in the outpatient setting

    Time frame: Single time point at baseline upon inclusion (cross-sectional)

    Number of participants with main reason due to heart failure from Coronary Artery Disease (CAD), Hypertension, Valvular, Idiopathic Dilated Cardiomyopathy, Congenital, Pregnancy / delivery related, or other reason to be specified

Secondary outcomes

  1. Measure investigations that heart failure patients undergo

    Time frame: Up to 6 months before inclusion

    Number of participants who have had echocardiography done less than 1 month, 1-6 months, greater than 6 months from enrollment

  2. Measuring patient functional status in heart failure patients

    Time frame: Single time point at baseline upon inclusion (cross-sectional)

    • Number of participants who can walk independently, walk with assistance, or are unable to walk.
    • Number of participants who are limited in dressing, somewhat limited, or not limited.
    • Number of participants who are can shower in a limited manner, somewhat limited, or not limited
  3. Relationship between cardiovascular risk factors and heart failure

    Time frame: Single time point at baseline upon inclusion (cross-sectional)

  4. Measuring Management Gaps in heart failure patients

    Time frame: Past 12 months upon inclusion

    • Number of participants with 0, 1, 2, or greater than 2 emergency room visits related to heart failure
    • Number of participants with 0,1, 2, or greater than 2 hospital admissions related to heart failure

Other outcomes

  1. Quantifying the distribution of heart failure types

    Time frame: Single time point at baseline upon inclusion (cross-sectional)

    Number of participants that will either have preserved or reduced left ventricular systolic function

Sponsors and collaborators

Lead sponsor

Gulf Heart Association

Other

Registry information

Official study title

Gulf Documentation of Ambulatory Sick Patients With Heart Failure Registry

Acronym: DYSPNEA

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jun 8, 2016
Registry last updated
May 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.